BACKGROUND: Reduction of radiation exposure from computed tomography coronary angiography (CTA) will be a key factor for more liberal use in cardiac hybrid positron emission tomography (PET)-computed tomography (CT). We report our initial experience with a new algorithm for low-dose CTA based on a prospectively gated step-and-shoot technique. This limits acquisition to the diastolic phase and minimizes exposure time versus the previous standard of retrospectively gated helical acquisitions. METHODS AND RESULTS: In 15 consecutive patients referred for integrated functional and morphologic workup by rubidium 82 perfusion PET-CTA, step-and-shoot CTA (SnapShot Pulse; GE Medical Systems) (120 kV, 600-800 mA) was acquired on a 64-slice GE Discovery Rx VCT PET-CT scanner and compared with a group of patients with conventional helical CTA (120 kV, with modulation of the milliampere level) who were matched with regard to clinical variables. Effective dose was estimated from dose-length product. The American Heart Association 15-segment coronary tree model was used to determine study interpretability. Potential for fusion with Rb-82 perfusion PET was tested by use of commercial software. In addition, direct dose measurements were conducted by use of an anthropomorphic phantom for more accurate dosimetry. The dose-length product-derived effective patient dose for step-and-shoot and helical CTA was 5.5 +/- 0.1 mSv versus 20.5 +/- 3.5 mSv (P < .0001). The mean number of evaluable segments per patient for the best phase of helical CTA was 12.5 +/- 2.8 (83.3% +/- 18.7%) versus 13.3 +/- 2.2 (88.7% +/- 14.7%) (P = not significant vs helical) for step-and-shoot CTA. Review of multiple phases increased the number for helical CTA to 13.7 +/- 1.7 (91.3% +/- 11.3%; P = not significant vs step-and-shoot CTA, for which this was not an option). Semiautomated fusion with corresponding PET was feasible for all studies. Phantom data confirm effective doses of 5.4 mSv for step-and-shoot CTA and 19.6 mSv for helical acquisition. CONCLUSIONS: Low-dose prospectively gated CTA reduces radiation exposure by nearly 70% versus the previous standard of helical acquisition, without significant loss in interpretability and integrative potential with Rb-82 perfusion PET. This represents a step toward a broader, routine integration of CTA and perfusion PET for assessment of coronary morphology and physiology by cardiac PET-CT.
BACKGROUND: Reduction of radiation exposure from computed tomography coronary angiography (CTA) will be a key factor for more liberal use in cardiac hybrid positron emission tomography (PET)-computed tomography (CT). We report our initial experience with a new algorithm for low-dose CTA based on a prospectively gated step-and-shoot technique. This limits acquisition to the diastolic phase and minimizes exposure time versus the previous standard of retrospectively gated helical acquisitions. METHODS AND RESULTS: In 15 consecutive patients referred for integrated functional and morphologic workup by rubidium 82 perfusion PET-CTA, step-and-shoot CTA (SnapShot Pulse; GE Medical Systems) (120 kV, 600-800 mA) was acquired on a 64-slice GE Discovery Rx VCT PET-CT scanner and compared with a group of patients with conventional helical CTA (120 kV, with modulation of the milliampere level) who were matched with regard to clinical variables. Effective dose was estimated from dose-length product. The American Heart Association 15-segment coronary tree model was used to determine study interpretability. Potential for fusion with Rb-82 perfusion PET was tested by use of commercial software. In addition, direct dose measurements were conducted by use of an anthropomorphic phantom for more accurate dosimetry. The dose-length product-derived effective patient dose for step-and-shoot and helical CTA was 5.5 +/- 0.1 mSv versus 20.5 +/- 3.5 mSv (P < .0001). The mean number of evaluable segments per patient for the best phase of helical CTA was 12.5 +/- 2.8 (83.3% +/- 18.7%) versus 13.3 +/- 2.2 (88.7% +/- 14.7%) (P = not significant vs helical) for step-and-shoot CTA. Review of multiple phases increased the number for helical CTA to 13.7 +/- 1.7 (91.3% +/- 11.3%; P = not significant vs step-and-shoot CTA, for which this was not an option). Semiautomated fusion with corresponding PET was feasible for all studies. Phantom data confirm effective doses of 5.4 mSv for step-and-shoot CTA and 19.6 mSv for helical acquisition. CONCLUSIONS: Low-dose prospectively gated CTA reduces radiation exposure by nearly 70% versus the previous standard of helical acquisition, without significant loss in interpretability and integrative potential with Rb-82 perfusion PET. This represents a step toward a broader, routine integration of CTA and perfusion PET for assessment of coronary morphology and physiology by cardiac PET-CT.
Authors: W G Austen; J E Edwards; R L Frye; G G Gensini; V L Gott; L S Griffith; D C McGoon; M L Murphy; B B Roe Journal: Circulation Date: 1975-04 Impact factor: 29.690
Authors: James P Earls; Elise L Berman; Bruce A Urban; Charlene A Curry; Judith L Lane; Robert S Jennings; Colin C McCulloch; Jiang Hsieh; John H Londt Journal: Radiology Date: 2008-01-14 Impact factor: 11.105
Authors: Daniel S Berman; Rory Hachamovitch; Leslee J Shaw; John D Friedman; Sean W Hayes; Louise E J Thomson; David S Fieno; Guido Germano; Nathan D Wong; Xingping Kang; Alan Rozanski Journal: J Nucl Med Date: 2006-07 Impact factor: 10.057
Authors: Marcelo F Di Carli; Sharmila Dorbala; Jolene Meserve; Georges El Fakhri; Arkadiusz Sitek; Stephen C Moore Journal: J Nucl Med Date: 2007-05 Impact factor: 10.057
Authors: Timothy F Christian; Mei Lee Frankish; Jennifer H Sisemoore; Madeline R Christian; George Gentchos; Stephen P Bell; Michael Jerosch-Herold Journal: J Nucl Cardiol Date: 2010-05-15 Impact factor: 5.952
Authors: Albert Flotats; Juhani Knuuti; Matthias Gutberlet; Claudio Marcassa; Frank M Bengel; Philippe A Kaufmann; Michael R Rees; Birger Hesse Journal: Eur J Nucl Med Mol Imaging Date: 2011-01 Impact factor: 9.236
Authors: Jens Vogel-Claussen; Jan Skrok; David Dombroski; Steven M Shea; Edward P Shapiro; Mark Bohlman; Christine H Lorenz; Joao A C Lima; David A Bluemke Journal: J Magn Reson Imaging Date: 2009-10 Impact factor: 4.813